Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

MK-8776

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Merck (MSD)

Drug class:

Chk1 inhibitor

Related drugs:

MYCN amplification	Neuroblastoma	MYCN amplification	Neuroblastoma	olaparib + MK-8776 Sensitive: D – Preclinical olaparib + MK-8776 Sensitive : D	olaparib + MK-8776 Sensitive: D – Preclinical olaparib + MK-8776 Sensitive : D
MYCN amplification	Medulloblastoma	MYCN amplification	Medulloblastoma	olaparib + MK-8776 Sensitive: D – Preclinical olaparib + MK-8776 Sensitive : D	olaparib + MK-8776 Sensitive: D – Preclinical olaparib + MK-8776 Sensitive : D
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	MK-8776 Sensitive: D – Preclinical MK-8776 Sensitive : D	MK-8776 Sensitive: D – Preclinical MK-8776 Sensitive : D